Why the study?
CIDEC mediates metabolic disturbance and insulin resistance, but whether it plays a critical role in diabetic cardiomyopathy remained to be investigated.
Does CIDEC gene silencing alleviate diabetic cardiomyopathy in preclinical models?
Population
Rat model of diabetic cardiomyopathy and in vitro insulin-resistant cardiac fibroblasts
Comparison
CIDEC gene silencing vs unsilenced models
Design
Preclinical in vivo animal and in vitro cellular study
Authors
Loading...
CIDEC silencing merits translational study in diabetic cardiomyopathy; hypothesis-generating in animal models only.
Does CIDEC gene silencing alleviate diabetic cardiomyopathy in preclinical models?
CIDEC gene silencing alleviates diabetic cardiomyopathy via AMPKα signaling in vivo and in vitro, suggesting it may be a promising therapeutic target.
Zhou et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: